Syndax Pharmaceuticals (SNDX) Short Interest Ratio & Short Volume → The Worst is Yet to Come… (From Porter & Company) (Ad) Free SNDX Stock Alerts $19.27 -0.02 (-0.10%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Syndax Pharmaceuticals Short Interest DataCurrent Short Interest10,030,000 sharesPrevious Short Interest10,110,000 sharesChange Vs. Previous Month-0.79%Dollar Volume Sold Short$220.06 millionShort Interest Ratio9.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares84,990,000 sharesPercentage of Shares Shorted11.80%Today's Trading Volume844,553 sharesAverage Trading Volume897,240 sharesToday's Volume Vs. Average94% Short Selling Syndax Pharmaceuticals ? Sign up to receive the latest short interest report for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNDX Short Interest Over TimeSNDX Days to Cover Over TimeSNDX Percentage of Float Shorted Over Time Ad Porter & CompanyThe Worst is Yet to Come…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. Syndax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202410,030,000 shares $220.06 million -0.8%N/A9.6 $21.94 4/30/202410,110,000 shares $213.62 million +5.3%N/A9.4 $21.13 4/15/20249,600,000 shares $207.55 million -0.2%N/A8.3 $21.62 3/31/20249,620,000 shares $228.96 million +15.5%N/A8.2 $23.80 3/15/20248,330,000 shares $195.92 million -8.4%N/A6.9 $23.52 2/29/20249,090,000 shares $213.07 million +5.7%N/A6.1 $23.44 Get the Latest News and Ratings for SNDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20248,600,000 shares $194.96 million -1.0%N/A5.8 $22.67 1/31/20248,690,000 shares $178.06 million No ChangeN/A5.8 $20.49 1/15/20248,690,000 shares $193.27 million +3.7%N/A5.4 $22.24 12/31/20238,380,000 shares $181.09 million -19.0%N/A4.7 $21.61 12/15/202310,340,000 shares $214.76 million +1.1%N/A4.8 $20.77 11/30/202310,230,000 shares $170.28 million -3.7%N/A5.4 $16.65 11/15/202310,620,000 shares $159.94 million +6.4%N/A6.2 $15.06 10/31/20239,980,000 shares $140.52 million +17.4%N/A6.1 $14.08 10/15/20238,500,000 shares $101.92 million +12.1%N/A5.7 $11.99 9/30/20237,580,000 shares $110.06 million -0.1%N/A6 $14.52 9/15/20237,590,000 shares $131.76 million +9.1%N/A9.8 $17.36 8/31/20236,960,000 shares $128.83 million -2.8%N/A8.8 $18.51 8/15/20237,160,000 shares $132.03 million +7.7%N/A8.4 $18.44 7/31/20236,650,000 shares $141.78 million +12.1%N/A7.4 $21.32 7/15/20235,930,000 shares $125.42 million +3.3%N/A6.8 $21.15 6/30/20235,740,000 shares $120.14 million +2.5%N/A6.5 $20.93 6/15/20235,600,000 shares $119.45 million -10.0%N/A5.9 $21.33 5/31/20236,220,000 shares $124.21 million -2.7%N/A6.7 $19.97 5/15/20236,390,000 shares $135.15 million -2.0%N/A7.4 $21.15 4/30/20236,520,000 shares $133.99 million -5.2%N/A7.9 $20.55 4/15/20236,880,000 shares $137.60 million -9.8%N/A8.6 $20.00 3/31/20237,630,000 shares $161.15 million +12.4%N/A9.5 $21.12 3/15/20236,790,000 shares $151.42 million +13.4%N/A8.9 $22.30 2/28/20235,990,000 shares $151.85 million +8.5%N/A7 $25.35 2/15/20235,520,000 shares $143.46 million +0.6%N/A6.8 $25.99 1/31/20235,490,000 shares $157.56 million +0.6%N/A6.5 $28.70 1/15/20235,460,000 shares $143.65 million -14.3%N/A6.4 $26.31 12/30/20226,370,000 shares $162.12 million +22.5%N/A7.3 $25.45 12/15/20225,200,000 shares $125.84 million +17.7%N/A6.1 $24.20 11/30/20224,420,000 shares $105.90 million +5.7%N/A5.8 $23.96 11/15/20224,180,000 shares $91.46 million +2.7%N/A6 $21.88 10/31/20224,070,000 shares $93.45 million -9.2%N/A5.9 $22.96 10/15/20224,480,000 shares $105.41 million +0.9%9.4%6.7 $23.53 9/30/20224,440,000 shares $106.69 million -3.5%9.3%6.7 $24.03What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. 9/15/20224,600,000 shares $113.02 million No Change9.6%7.2 $24.57 8/31/20224,600,000 shares $108.61 million +0.4%9.7%7 $23.61 8/15/20224,580,000 shares $113.31 million +5.1%9.6%7.1 $24.74 7/31/20224,360,000 shares $88.81 million +2.6%9.2%6.6 $20.37 7/15/20224,250,000 shares $80.92 million -24.8%9.2%6.8 $19.04 6/30/20225,650,000 shares $108.71 million -4.2%12.3%9.6 $19.24 6/15/20225,900,000 shares $95.76 million -0.7%12.8%10 $16.23 5/31/20225,940,000 shares $98.01 million -6.5%13.0%10.4 $16.50 5/15/20226,350,000 shares $89.60 million -1.6%13.9%10.9 $14.11 4/30/20226,450,000 shares $108.17 million +5.9%14.3%11.5 $16.77 4/15/20226,090,000 shares $110.47 million +9.1%13.5%11.1 $18.14 3/31/20225,580,000 shares $96.98 million -9.6%12.3%10.1 $17.38 3/15/20226,170,000 shares $99.21 million +18.9%13.8%11.6 $16.08 2/28/20225,190,000 shares $80.91 million +5.3%12.2%8.7 $15.59 2/15/20224,930,000 shares $81.69 million +17.1%11.6%8.7 $16.57 1/31/20224,210,000 shares $68.79 million +25.3%10.0%7.7 $16.34 1/15/20223,360,000 shares $60.78 million No Change7.5%5.8 $18.09 12/31/20213,360,000 shares $73.55 million -5.4%N/A6 $21.89 12/15/20213,550,000 shares $67.34 million +12.0%8.0%5.8 $18.97 11/30/20213,170,000 shares $50.62 million -6.8%7.4%5.8 $15.97 11/15/20213,400,000 shares $60.83 million -45.8%8.0%6.3 $17.89 10/29/20216,270,000 shares $121.95 million -1.0%14.6%11.6 $19.45 10/15/20216,330,000 shares $117.67 million -9.1%14.7%13.1 $18.59 9/30/20216,960,000 shares $133.01 million -11.0%16.2%13.8 $19.11 9/15/20217,820,000 shares $151.40 million -5.2%18.2%15.7 $19.36 8/31/20218,250,000 shares $144.29 million +2.7%19.2%17.9 $17.49 8/13/20218,030,000 shares $127.76 million -2.0%18.8%17.5 $15.91 7/30/20218,190,000 shares $119.41 million -5.2%19.4%16.6 $14.58 7/15/20218,640,000 shares $133.06 million +10.1%20.5%14.7 $15.40 6/30/20217,850,000 shares $134.78 million +1.7%18.6%9.8 $17.17 6/15/20217,720,000 shares $147.84 million +2.5%18.3%9.4 $19.15 5/28/20217,530,000 shares $138.33 million +3.9%17.9%8.8 $18.37 5/14/20217,250,000 shares $131.30 million -1.2%N/A7.7 $18.11 4/30/20217,340,000 shares $117.07 million +16.3%N/A7.9 $15.95 4/15/20216,310,000 shares $136.80 million -7.1%N/A7 $21.68 3/31/20216,790,000 shares $142.32 million +27.9%N/A10.1 $20.96 3/15/20215,310,000 shares $121.65 million +7.7%N/A7.4 $22.91 2/26/20214,930,000 shares $114.82 million No ChangeN/A7 $23.29 2/12/20214,930,000 shares $103.83 million +2.1%N/A7.5 $21.06 1/29/20214,830,000 shares $97.32 million -10.2%N/A7.1 $20.15 1/15/20215,380,000 shares $130.63 million -2.5%N/A7.3 $24.28 12/31/20205,520,000 shares $126.13 million +15.7%N/A7.7 $22.85 12/15/20204,770,000 shares $121.06 million +5.3%N/A7 $25.38 11/30/20204,530,000 shares $103.60 million -1.5%N/A7.3 $22.87 11/15/20204,600,000 shares $96.60 million +5.0%N/A9 $21.00 10/30/20204,380,000 shares $79.02 million -4.8%N/A9.3 $18.04 10/15/20204,600,000 shares $73.42 million +2.5%N/A12.6 $15.96 9/30/20204,490,000 shares $66.27 million +23.0%N/A14.8 $14.76 9/15/20203,650,000 shares $63.80 million +1.7%N/A11.3 $17.48 8/31/20203,590,000 shares $58.55 million +1.4%N/A11.4 $16.31What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. 8/14/20203,540,000 shares $56.04 million +3.5%N/A9.1 $15.83 7/31/20203,420,000 shares $48.26 million -4.7%N/A5.9 $14.11 7/15/20203,590,000 shares $51.91 million -6.0%N/A3.9 $14.46 6/30/20203,820,000 shares $55.24 million +18.6%N/A4.2 $14.46 6/15/20203,220,000 shares $49.91 million +11.4%N/A3.7 $15.50 5/29/20202,890,000 shares $46.82 million +28.4%11.4%3.4 $16.20 5/15/20202,250,000 shares $41.67 million +27.8%8.8%2.8 $18.52 4/30/20201,760,000 shares $31.68 million -0.6%7.8%3 $18.00 4/15/20201,770,000 shares $19.29 million -1.7%7.8%6.8 $10.90 3/31/20201,800,000 shares $21.06 million +49.1%8.0%7.1 $11.70 3/13/20201,207,200 shares $12.24 million +34.7%5.4%4.4 $10.14 2/28/2020896,300 shares $8.17 million +6.4%4.0%4.3 $9.11 2/14/2020842,100 shares $10.00 million +21.8%3.9%4.6 $11.87 1/31/2020691,300 shares $7.49 million +13.4%3.0%4.1 $10.84 1/15/2020609,700 shares $5.65 million +0.5%3.0%5.4 $9.26 12/31/2019606,500 shares $4.27 million +2.0%3.0%5 $7.04 SNDX Short Interest - Frequently Asked Questions What is Syndax Pharmaceuticals' current short interest? Short interest is the volume of Syndax Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 10,030,000 shares of SNDX short. Learn More on Syndax Pharmaceuticals' current short interest. What is a good short interest ratio for Syndax Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNDX shares currently have a short interest ratio of 10.0. Learn More on Syndax Pharmaceuticals's short interest ratio. Which institutional investors are shorting Syndax Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Syndax Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Syndax Pharmaceuticals' short interest increasing or decreasing? Syndax Pharmaceuticals saw a drop in short interest in May. As of May 15th, there was short interest totaling 10,030,000 shares, a drop of 0.8% from the previous total of 10,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Syndax Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Syndax Pharmaceuticals: Evotec SE (0.04%), Structure Therapeutics Inc. (9.82%), Summit Therapeutics Inc. (27.20%), Harmony Biosciences Holdings, Inc. (23.14%), NewAmsterdam Pharma (0.37%), Protagonist Therapeutics, Inc. (5.92%), Keros Therapeutics, Inc. (6.74%), Kura Oncology, Inc. (16.27%), Galapagos NV (2.43%), Schrödinger, Inc. (10.86%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Syndax Pharmaceuticals stock? Short selling SNDX is an investing strategy that aims to generate trading profit from Syndax Pharmaceuticals as its price is falling. SNDX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Syndax Pharmaceuticals? A short squeeze for Syndax Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNDX, which in turn drives the price of the stock up even further. How often is Syndax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNDX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: EVO Short Squeeze GPCR Short Squeeze SMMT Short Squeeze HRMY Short Squeeze NAMS Short Squeeze PTGX Short Squeeze KROS Short Squeeze KURA Short Squeeze GLPG Short Squeeze SDGR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNDX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.